Related Experiment Video

Updated: Mar 11, 2026

A High-content Assay for Monitoring AMPA Receptor Trafficking
10:34

A High-content Assay for Monitoring AMPA Receptor Trafficking

Published on: January 28, 2019

8.1K

GSK-3: A key regulatory target for ketamine's rapid antidepressant effects mediated by enhanced AMPA to

Carlos A Zarate1, Rodrigo Machado-Vieira1

  • 1Experimental Therapeutics and Pathophysiology Branch, Intramural Research Program, National Institute of Mental Health, National Institutes of Health, Bethesda, MD, USA.

Bipolar Disorders
|December 1, 2016
PubMed
Abstract

No abstract available in PubMed .

Keywords:
glycogen synthase kinase 3 (GSK-3)ketamineα-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA)

More Related Videos

A High-throughput Calcium-flux Assay to Study NMDA-receptors with Sensitivity to Glycine/D-serine and Glutamate
04:48

A High-throughput Calcium-flux Assay to Study NMDA-receptors with Sensitivity to Glycine/D-serine and Glutamate

Published on: July 10, 2018

9.8K
BS3 Chemical Crosslinking Assay: Evaluating the Effect of Chronic Stress on Cell Surface GABAA Receptor Presentation in the Rodent Brain
05:17

BS3 Chemical Crosslinking Assay: Evaluating the Effect of Chronic Stress on Cell Surface GABAA Receptor Presentation in the Rodent Brain

Published on: May 26, 2023

1.7K

Related Experiment Videos

Last Updated: Mar 11, 2026

A High-content Assay for Monitoring AMPA Receptor Trafficking
10:34

A High-content Assay for Monitoring AMPA Receptor Trafficking

Published on: January 28, 2019

8.1K
A High-throughput Calcium-flux Assay to Study NMDA-receptors with Sensitivity to Glycine/D-serine and Glutamate
04:48

A High-throughput Calcium-flux Assay to Study NMDA-receptors with Sensitivity to Glycine/D-serine and Glutamate

Published on: July 10, 2018

9.8K
BS3 Chemical Crosslinking Assay: Evaluating the Effect of Chronic Stress on Cell Surface GABAA Receptor Presentation in the Rodent Brain
05:17

BS3 Chemical Crosslinking Assay: Evaluating the Effect of Chronic Stress on Cell Surface GABAA Receptor Presentation in the Rodent Brain

Published on: May 26, 2023

1.7K

Related Concept Videos

Antiepileptic Drugs: Glutamate Antagonists01:14

Antiepileptic Drugs: Glutamate Antagonists

1.1K
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
1.1K
GPCR Desensitization01:12

GPCR Desensitization

8.5K
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
8.5K

Articles linked to this work by shared authors, journal, and citation graph.

Effects of psychedelic drug use on neurocognitive function and the psychological and social domains of quality of life: an international online study.

Frontiers in psychiatry·2026

Treatments for Individuals with Suicidal Thoughts: Use, Indications, and Helpfulness.

Journal of affective disorders reports·2026

Modulation of GABA and glutamate by ketamine in depression: A systematic review and meta-analysis of magnetic resonance spectroscopy studies.

Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2026

Plasma copeptin is coupled to resting-state frontoinsular-subgenual alpha dynamics in major depression with comorbid post-traumatic stress disorder.

Frontiers in endocrinology·2026

The Antidepressant Effects of the mGlu2/3 Receptor Antagonist TS-161 in Treatment-Resistant Depression: A Phase IIa Proof-of-Concept Clinical Trial.

Journal of clinical psychopharmacology·2026

Electrophysiological Markers of Within-Network Connectivity in Major Depression.

medRxiv : the preprint server for health sciences·2026

The Impact of Sexual Satisfaction on Marital Adjustment, Quality of Life, and Treatment Adherence in Patients Diagnosed With Bipolar Disorder and Their Spouses: A Cross-Sectional Study.

Bipolar disorders·2026

Emotional Responses (Intensity/Valence) Fulfill RDoC Criteria but Remain Excluded From Diagnostic Classifications of Mood Disorders.

Bipolar disorders·2026

'It's a Balancing Act': A Qualitative Analysis of the Experiences of Caffeine Use in Individuals With Bipolar Disorder.

Bipolar disorders·2026

Irritability in the Mix: An Exploratory Study of the Role of Irritability in Characterising Mood Disorders.

Bipolar disorders·2026

Trajectories of Cognitive Functioning in Older Age Bipolar Disorder.

Bipolar disorders·2026

Bipolar Disorder and Perimenopause: An Update.

Bipolar disorders·2026

Role of subcortical iron in Parkinson's disease, prodromal-depression, and dementia: Comparative links to anemias and osteoporosis.

Journal of Alzheimer's disease : JAD·2026

Low-level of mitochondrial DNA alterations during direct-acting antiviral treatment in leukocytes of people who inject drugs living with HCV.

Microbiology spectrum·2026

Clinical Efficacy of Polypill with a Focus on Blood Pressure Control: A Systematic Review and Meta-analysis.

Current hypertension reviews·2026

Development of Selenized Phytosomes for Sustained Release of Berberine and Synergistic Hypoglycemic Effect.

Current pharmaceutical design·2026

Exploring Isatin Derivatives as Multifunctional Antidiabetic Agents: Insights into α-Glucosidase and α-Amylase Inhibition.

Mini reviews in medicinal chemistry·2026

Obstetric Pharmacomicrobiomics.

Clinical pharmacology and therapeutics·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us